Shared on31 Aug 25Fair value Increased 10%
Despite a notable downward revision in revenue growth forecasts and a higher discount rate, the consensus analyst price target for McMillan Shakespeare has increased from A$18.11 to A$19.08. Valuation Changes Summary of Valuation Changes for McMillan Shakespeare The Consensus Analyst Price Target has risen from A$18.11 to A$19.08.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on13 Mar 25Fair value Decreased 0.92%
AnalystConsensusTarget has increased revenue growth from 2.1% to 2.9%.